Tuesday, September 6, 2016
Immortagen, Inc., a University of Iowa spinoff venture, announced it has completed its Series A equity financing. Led by John Pappajohn of Des Moines, Iowa, Immortagen has already hired its initial scientists and begun increasing its industry presence, while pushing forward with several product platforms. Launched in 2014 by UI researchers Donghai Dai, M.D., Ph.D., MS; Kristina Thiel, Ph.D.; Baoli...